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Figure S1, related to Figure 1: Ectopic expression of microRNA-132 leads to 
dregulated hematopoiesis. (A) miR-212 expression in total bone marrow and HSCs. (B) 
Schematic of the retroviral construct used to over-express miR-132 and reconstitution 
efficiency of mice transplanted with MG or miR-132 donor bone marrow. Peripheral 
blood was analyzed at 8-weeks post-reconstitution for the proportion of eGFP+ CD45+ 
leukocytes. (C) Expression of miR-132 in bone marrow cells obtained from MG and 
miR-132 mice. Data is represented as mean ± SEM. (D) – (U) WT C57BL/6 mice were 
lethally irradiated and reconstituted with donor bone marrow cells expressing either a 
control (MG) or a miR-132 over-expressing (miR-132) retroviral vector (n=8-12 mice per 
group). Data represents at least three independent experiments and is shown for 16-weeks 
post-reconstitution unless otherwise specified. (D) Total number of LSK cells in the bone 
marrow at 8-weeks post-reconstitution. (E) Frequency of HSCs in the bone marrow at 8-
weeks post-reconstitution. (F) Frequency of LSK cells in the bone marrow at 8-weeks 
post-reconstitution. (G) Percentage of Ki-67+ cells within the bone marrow LSK at 8-
weeks post-reconstitution. (H) p27, p57, and p21 transcript expression in the bone 
marrow at 2-months post-reconstitution. (I) p27 transcript expression in the bone marrow 
compartment at 4-months post-reconstitution. (J) Spleen weights. (K) Percentage of 
Ter119+, CD11b+ and Gr-1+ cells in the spleen. (L) Total number of  CD11b+ and Gr-
1+ cells in the peripheral blood. (M) Representative FACS plot and gating for HSCs 
(Lineage- Sca1+ cKit+ CD150+ CD48-). (N) Percentage of LSK cells and HSCs in the 
bone marrow. (O) Total number of LSK cells and HSCs at 9-months post-reconstitution. 
Total number of (P) multipotent progenitors (MPPs), (Q) lymphoid primed MPPs 
(LMPPs), (R) granulocyte-monocyte progenitors (GMPs), (S) common myeloid 
progenitors (CMPs), and (T) myeloid-erythroid progenitors (MEPs) in the bone marrow. 
(U) Percentage of HSCs in the bone marrow within the eGFP- population. (V) WT 
C57BL/6 mice were lethally irradiated and reconstituted with donor bone marrow cells 
expressing either a control (MG) or a miR-132-mutant over-expressing (miR-132-
mutant) retroviral vector in which the miR-132 seed sequence was mutated (n=5 mice per 
group). Graphs show total peripheral blood CD45+ leukccytes and CD11b+ cells at 9-
months post-reconstitution. (W) – (Y) WT C57BL/6 mice were lethally irradiated and 
reconstituted with donor bone marrow cells expressing either a control (MG) or a miR-
212 over-expressing (miR-212) retroviral vector (n=4 mice per group). (W) Total bone 
marrow CD45+ cells. (X) Frequency and total number of LSK cells in the bone marrow. 
(Y) Frequency and total number of HSCs in the bone marrow. Data is represented as 
mean ± SEM. * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001 using a 
Student’s t test. 
 




















































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S2, related to Figures 2 and 3: Genetic deletion of Mirc19 in mice leads to 
deregulated hematopoiesis with age. (A) – (C) Mice with a genetic deletion of Mirc19 
(Mirc19-/-) along with WT mice in the C57BL/6 background were analyzed to understand 
the physiological contribution of Mirc19 on hematopoietic output (n=7-8 mice per 
group). (A) Total number of peripheral blood CD45+, CD19+ and CD11b+ cells at 12-
weeks of age. (B) Total number of splenic CD45+, CD19+ and CD11b+ cells at 12-
weeks of age. (C) Total number of bone marrow CD45+, CD19+ and CD11b+ cells at 
12-weeks of age. (D) Total number of HSCs in the bone marrow at 12-weeks of age. (E) 
Spleen weight, and percentage of splenic CD11b+, CD19+ and CD3e+ cells at 60-64 
weeks of age. (F) Total number of CD45+, CD11b+, CD19+ and CD3e+ cells in the bone 
marrow at 60-64 weeks of age. (G) WT or Mirc19-/- (KO) bone marrow cells were 
transplanted into lethally irradiated C57BL/6 mice. The relative ratio (KO/WT) of total 
numbers of various cell populations in the bone marrow of these mice at 60-weeks post-
reconstitution is shown. (H) – (J) 6-month old WT and Mirc19-/- mice were treated with 9 
evenly-spaced low-dose (1mg/kg of body weight) LPS or PBS injections over one month. 
(H) Total number of HSCs in the spleen. (I) Relative proportions of early progenitors in 
the bone marrow. (J) Proportion of bone marrow LSK cells and HSCs in each stage of the 
cell cycle (G0, G1, G2/M). (K) Expression of p27 in the bone marrow compartment. (L) 
Expression of p27 in the bone marrow compartment of mice 5-days after a single 
treatment of 5-fluorouracil. (M) WT or Mirc19-/- CD45.2+ bone marrow cells from 
primary transplant experiments, calibrated for the total number of phenotypically defined 
HSCs, were injected in a 1:1 ratio with CD45.1+ WT bone marrow cells into irradiated 
C57BL/6 CD45.2+ recipients. The graph represents the relative ratio of mature cells in 
the peripheral blood of these secondary transplant mice at 16-weeks post-reconstitution. 
(O) Summary of the number of detected protein coding genes and FPKM values for 
sequenced samples. LT-HSC: long-term HSCs, LSK CD150+ CD48-. SH-HSCs: short-
term HSCs, LSK CD150- CD48-. MPPs: multipotent progenitors, LSK CD150- CD48+. 
WT: wildtype sample. KO: Mirc19-/- sample. (O) Box-plot showing enrichment of miR-
132 targets in miR-212/132-/- HSCs compared to WT HSCs. (P) Fold-change of several 
miR-132 targets in miR-212/132-/- HSCs compared to WT HSCs. (Q) Fold-change in 
several FOXO3 regulated genes in miR-212/132-/- HSCs compared to WT HSCs. (R) 
Fold-change in several autophagy related genes in miR-212/132-/- HSCs Data represents 
at least two independent experiments and is represented as mean ± SEM. * denotes p < 




























































































































































































































Figure S3, related to Figures 6 and 7: Validation of microRNA-132 and FOXO3 over-
expression in FOXO3 rescue experiment. (A) FOXO1 and FOXO4 expression in total 
bone marrow cells from WTMG and WTmiR-132 mice. (B) FOXO1 and FOXO4 expression 
in lineage-depleted bone marrow cells from WT and miR-212/132-/- mice. RNA was 
obtained from the respective cell populations and FOXO1 and FOXO4 expression was 
quantified by RT-qPCR (n=2-3 biological replicates). (C) Intracellular staining analyzed 
by FACS for FOXO3 protein expression in bone marrow HSCs obtained from WT and 
miR-212/132-/- mice and starved for 12 hours in-vitro. (D) Intracellular staining analyzed 
by FACS for phosphorylated FOXO3 (p-FOXO3) protein expression in bone marrow 
HSCs obtained from WT and miR-212/132-/- mice and starved for 12 hours in-vitro. (E) – 
(F) Bone marrow expressing either a control (MIG), a miR-132 over-expressing (MIG-
miR-132), a FOXO3 over-expressing (MIG-FOXO3), or a FOXO3 and miR-132 over-
expressing (MIG-FOXO3-miR-132) retroviral vector were analyzed using Taqman RT-
qPCR for miR-132 expression or Western Blot for FOXO3 protein expression. (E) 
FOXO3 protein expression in bone marrow cells transduced with the indicated retroviral 
vectors. (F) Mature miR-132 expression in in bone marrow cells transduced with the 
indicated retroviral vectors. (G) eGFP expression in the bone marrow compartment of 
mice reconstitution with bone marrow cells transduced with the indicated retroviral 
vector. (H) AnnexinV staining performed on bone marrow HSCs from MIG and MIG-
FOXO3 mice (n=3). (I) Detection of autophagy activity using the Cyto-ID autophagy 
detection assay in bone-marrow-derived dendritic cells treated with Rapamycin and 
obtained from WT and Atg16 deficient (Atg16 KO) mice. Data represents at least two 
independent experiments and is represented as mean ± SEM.  
Supplemental	  Experimental	  Procedures	  
DNA	  Constructs	  
The miR-132 over-expression construct was cloned into the MSCV-eGFP (MG) vector. 
In this modified vector, MG-miR-132, containing an MSCV promoter, the eGFP is 
placed immediately downstream of the 5’ LTR and the miR-132 expression cassette is 
placed immediately downstream of the eGFP stop codon. A miR-132-mutant vector was 
similar constructed with a mutated miR-132 seed sequence. For FOXO3 rescue 
experiments, FOXO3 cDNA was cloned into the MSCV-IRES-eGFP (MIG) vector, 
immediately downstream of the 5’ LTR and upstream of the IRES. miR-132 was cloned 
downstream of eGFP as described above. For FOXO3 knockdown experiments, TagBFP 
was first subcloned into the MG vector, creating MSCV-TagBFP (MB). Several FOXO3 
shRNA sequences were designed using the Invitrogen Block-iT RNAi Designer and 
cloned in the microRNA-155 loop-and-arms format immediately downstream of TagBFP 
in the MB vector.  
 
Cell	  sorting	  for	  RNA	  extraction	  
Bone marrow cells were harvested from WT C57BL/6 mice and depleted of red blood 
cells (RBCs) using RBC lysis buffer (BioLegend). Cells were then spun down, 
resuspended in MACS separating buffer (Phosphate buffered saline, pH7.2, with 0.5% 
BSA and 2mM EDTA) and filtered through a 70uM cell-strainer. These cells were then 
blocked with FcBlock (Becton Dickinson) and depleted of mature cells on a magnetic 
column using biotin-conjugated mouse antibodies for CD3e, CD8, CD4, CD19, B220, 
CD11b, Gr-1, IL-7Ra, and Ter119 (BioLegend) and streptavidin magnetic beads 
(Miltenyi), as suggested by the manufacturer (Miltenyi). Cells were subsequently stained 
with fluorophore-conjugated antibodies for lineage markers (CD3, CD19, CD11b, Gr-1, 
Ter119, Nk1.1), cKit, Sca1, CD150, CD48 and with 7-AAD, and several populations 
were sorted for analysis including HSCs (Lineage- cKit+ Sca1+ CD150+ CD48-), LSK 
cells (Lineage- cKit+ Sca1+), and other progenitor subsets as detailed in the text. Cells 
were sorted on a FACSAria IIu cell sorter (Becton Dickinson) at the Caltech Flow 
Cytometry Core Facility. Mature cell populations were sorted using a magnetic column 
as described above using positive-selection for the respective surface marker (Gr-1, 
CD11b, CD19). All cells were lysed using Qiazol lysis buffer (Qiagen) and processed 
using the miRNAeasy RNA prep kit (Qiagen). RNA was then subjected to qPCR.  
 
Sample preparation for RNA-sequencing 
LT-HSCs (LSK CD150+ CD48-), ST-HSCs (LSK CD150- CD48-) and MPPs (LSK 
CD150- CD48+) from WT and miR-212/132-/- were sorted as described above. Cells 
were sorted directly into cell lysis buffer and processed using an RNAeasy kit (Qiagen) 
with DNAseI digestion (Qiagen) as per manufacturer’s protocol. Libraries were prepared 
using the SMART-seq2 protocol (Picelli et al., 2013) modified to use Maxima H Minus 
enzyme for reverse transcription (Thermo Scientific) (Satija et al., 2015). Amplified 
cDNA products were purified using AMPure XP SPRI beads (Beckman Coulter) and 
eluted in TE buffer (Teknova). Cleaned-up amplified cDNA was used for library 
construction using the Nextera XT DNA Sample Preparation Kit and Nextera XT Index 
Kit (Illumina). Libraries were then pooled and cleaned-up using AMPure XP SPRI beads 
(Beckman Coulter Genomics). Final library quality and quantity were assessed using a 
DNA High Sensitivity chip (Agilent).  
 
RNA-seq data generation and analysis 
Libraries were sequenced on the Illumina HiSeq 2500. Paired-end 2x25bp reads were 
generated. The reads were filtered for rRNA contamination by aligning against mouse 
ribosomal sequences using Bowtie (version 0.12.7) (Langmead et al., 2009), and 
retaining unaligned read pairs. The refSeq annotation for the mm9 version of the mouse 
genome was used to create a transcriptome Bowtie index, to which read pairs were 
aligned with the following settings: “-v 2 -a -X 1000”. Gene expression levels were 
estimated using eXpress (version 1.5.1) (Roberts and Pachter, 2013), and the effective 
count values were used as input to DESeq (Anders and Huber, 2010) for evaluating 
differential expression. The targets of miR-132 were obtained from TargetScan (mouse 
release 6.2) (Friedman et al., 2009). 
 
Immunoblotting 
Pelleted cells were resuspended in RIPA lysis buffer (Sigma) containing protease 
inhibitors for 20 minutes on ice. Samples were spun down at max speed at 4oC for 10 
minutes and the supernatant was processed immediately or flash-frozen on dry ice for 
analysis in the future. Total cell extracts were fractionated by gel-electrophoresis on a 
mini-PROTEAN TGX gradient (4-15%) gel (Bio-Rad) and electroblotted onto a PVDF 
membrane using a wet transfer apparatus (Bio-Rad). Protein detection was subsequently 
performed with the following antibodies: FoxO3a (75D8) (Cell Signaling Technologies), 
p27-HRP (sc-538) (Santa Cruz Biotechnology), actin-HRP (sc-1616) (Santa Cruz 
Biotechnology) and goat anti-rabbit-IgG-HRP (sc-2030) (Santa Cruz Biotechnology).  
	  
Mice	  All	  mice	  used	  in	  this	  study	  are	  of	  the	  C57BL/6	  background.	  The	  miR-­‐212/132-­‐/-­‐	  mice	  were	  generated	  previously	  and	  are	  described	  elsewhere	  (Ucar	  et	  al.,	  2012).	  Briefly,	  these	  mice	  were	  generated	  by	  homologous	  recombination	  targeting	  the	  genomic	  cluster	  containing	  both	  microRNA-­‐212	  and	  microRNA-­‐132.	  Mice	  obtained	  were	  backcrossed	  to	  the	  C57BL/6	  background	  for	  at	  least	  20	  generations	  prior	  to	  the	  initiation	  of	  the	  reported	  studies.	  	  
	  
Bone	  marrow	  reconstitution	  WT	  C57BL/6	  or	  miR-­‐212/132-­‐/-­‐	  mice	  were	  treated	  with	  5-­‐fluorouracil	  (10ug;	  Sigma)	  for	  5	  days	  to	  enrich	  for	  hematopoietic	  stem	  and	  progenitor	  cells	  (HSPCs)	  in	  the	  bone	  marrow.	  After	  5	  days,	  bone	  marrow	  cells	  were	  harvested,	  red	  blood	  cells	  (RBCs)	  were	  lysed	  with	  RBC	  lysis	  buffer	  (BioLegend),	  and	  cells	  were	  plated	  in	  HSPC	  media	  which	  was	  comprised	  of	  complete	  RPMI	  with	  mouse	  SCF	  (50	  ng/mL),	  IL-­‐3	  (20	  ng/mL),	  and	  IL-­‐6	  (50	  ng/mL).	  Cells	  were	  then	  cultured	  in	  24-­‐wel	  plates	  for	  24	  hours	  and	  spin-­‐infected	  with	  PCL-­‐ecotropic	  pseudotyped	  gamma-­‐retrovirus	  expressing	  the	  construct	  of	  interest,	  which	  was	  either	  a	  microRNA,	  shRNA	  or	  a	  gene,	  as	  described	  in	  under	  the	  DNA	  Constructs	  and	  Primers	  section	  of	  the	  main	  text.	  Spin-­‐infections	  were	  performed	  by	  removing	  supernatant	  carefully	  from	  cell	  culture	  plates	  and	  adding	  virus	  with	  8	  ug/mL	  Polybrene	  (Santa	  Cruz	  Biotechnology).	  Plates	  
were	  then	  placed	  in	  a	  centrifuge	  for	  2	  hours	  at	  300C	  and	  2500RPM.	  Immediately	  following	  infection,	  virus	  supernatant	  was	  removed	  and	  replaced	  with	  HSPC	  media.	  24	  hours	  later	  a	  second	  identical	  spin	  infection	  was	  performed.	  After	  another	  24	  hours,	  recipient	  mice	  were	  lethally	  irradiated	  (1000	  rads	  from	  Cs137	  source)	  and	  250,000	  to	  a	  million	  virus-­‐infected	  HSPCs	  were	  retro-­‐orbitally	  delivered	  to	  reconstitute	  the	  immune	  system.	  Recipients	  were	  maintained	  on	  Septra	  and	  in	  autoclaved	  cages	  for	  at	  least	  one	  month	  post-­‐reconstitution.	  	  	  
Virus	  production	  To	  generate	  retrovirus	  for	  HSPC	  infection,	  10	  million	  HEK293T	  cells	  were	  first	  plated	  in	  a	  15cm	  plate.	  24	  hours	  later,	  cells	  were	  transfected	  with	  both	  the	  pCL-­‐Eco	  vector	  and	  either	  the	  pMG	  vector	  or	  the	  relevant	  variant	  described	  above	  for	  gene	  delivery.	  For	  transfection,	  we	  used	  BioT	  (Bioland	  Scientific)	  as	  per	  the	  manufacturers	  protocol.	  36	  hours	  after	  transfection,	  virus	  was	  collected,	  filtered	  through	  a	  45uM	  syringe	  filter,	  and	  used	  for	  infection	  of	  HSPCs.	  	  
Flow	  cytometry	  
Cells were stained with fluorophore-conjugated antibodies (all from BioLegend unless 
indicated) for CD45.1, CD45.2, CD11b, Gr-1, CD19, B220, CD3e, Nk1.1, Ter119, cKit, 
Sca1, CD150, CD48, EPCR (Ebioscience), CD34, Flt3, FcRg or IL-7Ra in various 
combinations to characterize relevant hematopoietic cell populations. Intracellular 
staining was performed by first performing surface staining of cells, followed by fixation 
and permeabilization (Cytofix/Cytoperm kit; BD Biosciences) and subsequent staining 
with either Ki67 (BioLegend) and Hoescht33342 (Life Technologies) for cell-cycling 
analysis, or an anti-FoxO3a (75D8) (Cell Signaling Technologies) or anti-FoxO3a 
(phosphor S253) (Abcam) primary antibody followed by an anti-Rabit-IgG secondary 
antibody conjugated to Alexafuor488 (Cell Signaling Technologies). Samples were 
analyzed on a MACSQuant10 Flow Cytometry machine (Miltenyi). Gating and analysis 
was performed using FlowJo software. 
 
Autophagy	  and	  reactive-­‐oxygen	  species	  assays	  
HSCs were sorted as described above from either WT or miR-212/132-/- C57BL/6 mice, 
or from reconstituted mice with donor WT or miR-212/132-/- bone marrow infected with 
either MB or shFOXO3 retroviral constructs. For all in-vitro experiments, cells were 
sorted directly in a 96-wel plate containing cell culture media with the appropriate growth 
factors and cytokines (all from Ebioscience). For caspase activation assays and reactive 
oxygen species detection, 5000 cells were cultured with or without Bafilomycin A (5nM; 
Sigma) and with either no growth factors or cytokines, or with mSCF (50 ng/mL), IL-3 
(20 ng/mL), IL-6 (50 ng/mL), Flt3L (25 ng/mL), TPO (25 ng/mL), and GM-CSF 
(10ng/mL). Cells were cultured for 12 hours and subsequently processed. Caspase 
activity was detected using the luciferase-based Caspase Glo 3/7 assay system as per 
manufactures instructions (Promega). Reactive-oxygen species were detected by flow 
cytometry using the CellROX Deep Red reagent (Life Technologies). For authophagy 
detection assays, 5000-8000 cells were cultured with or without LY294002 (20uM; Cell 
Signaling Technologies) and with or without aforementioned growth factors or cytokines. 
Autophagy activity was determined by flow cytometry using the CytoID autophagy 





















Table	  S1,	  related	  to	  DNA	  Constructs	  in	  Experimental	  Procedures.	  Sequences	  for	  FOXO3	  shRNA	  constructs.	  These	  sequences	  were	  cloned	  into	  the	  MSCV-­‐eGFP	  retroviral	  vector	  to	  silence	  FOXO3	  expression	  in	  bone	  marrow	  cells.	  
FOXO3 shRNA sequence (in miR-155-arms-and-loop-format) 
mmu-FOXO3 shRNA #1 gaaggctgtaTGCTGCCATCATTCAGATTCATGGTGGTTTTGGCCACTGACTGACCACCATGACTGAATGATGGcaggacacaaggcctg 
mmu-FOXO3 shRNA #2 gaaggctgtaTGCTGAACACGGTACTGTTGAAGGAGGTTTTGGCCACTGACTGACCTCCTTCAAGTACCGTGTTcaggacacaaggcctg 



















Table	  S2,	  related	  to	  Expression	  profiling	  and	  qPCR	  in	  Experimental	  Procedures.	  Primer	  sequences	  used	  for	  qPCR	  to	  quantify	  expression	  of	  various	  genes.	  These	  forward	  (F)	  and	  reverse	  (R)	  primers	  were	  used	  to	  quantify	  mRNA	  expression	  of	  various	  genes	  using	  RT-­‐qPCR.	  
Primer sequences 
AchE F CTCCCTGGTATCCCCTGCATA 
AchE R GGATGCCCAGAAAAGCTGAGA 
BTG2 F ATGAGCCACGGGAAGAGAAC 
BTG2 R GCCCTACTGAAAACCTTGAGTC 
FOXO1 F CCCAGGCCGGAGTTTAACC 
FOXO1 R GTTGCTCATAAAGTCGGTGCT 
FOXO3 F CTGGGGGAACCTGTCCTATG 
FOXO3 R TCATTCTGAACGCGCATGAAG 
HMGA2 F GAGCCCTCTCCTAAGAGACCC 
HMGA2 R TTGGCCGTTTTTCTCCAATGG 
JARID1A F CACAGACCCGCTGAGTTTTAT 
JARID1A R CTTCACAGGCAAATGGAGGTT 
Lin28b F AGAATGCAGTCTACCTCCTCAG 
Lin28b R CCTCCCACTTCTCTTGGTGC 
MAPK1 F GGTTGTTCCCAAATGCTGACT 
MAPK1 R CAACTTCAATCCTCTTGTGAGGG 
MMP9 F CTGGACAGCCAGACACTAAAG 
MMP9 R CTCGCGGCAAGTCTTCAGAG 
p21 F CCGCTGGAGGGCAACTTCGT  
p21 R TTTCGGCCCTGAGATGTTCC 
p27 F  TCTCAGGCAAACTCTGAGGAC  
p27 R TTCGGAGCTGTTTACGTCTGG 
p300 F CTCGCACTTGCCCTTACCTTT 
p300 R GGTCGCAGTGGCTGGAGA 
p57 F TGATGAGCTGGGAACTGAGCC 
p57 R ACGTCGTTCGACGCCTTGTTC 
PTBP2 F GGATCTGACGAGCTACTCTCA 
PTBP2 R TTCTTACTATCGTTACCGTTGGC 
RB1 F TGCATCTTTATCGCAGCAGTT 
RB1 R GTTCACACGTCCGTTCTAATTTG 
SOX4 F GACAGCGACAAGATTCCGTTC 
SOX4 R GTTGCCCGACTTCACCTTC 
SOX5 F CCCGTGATCCAGAGCACTTAC 
SOX5 R CCGCAATGTGGTTTTCGCT 
Supplemental References 
Anders, S., and Huber, W. (2010). Differential expression analysis for sequence count 
data. Genome Biol 11, R106. 
 
Friedman, R.C., Farh, K.K., Burge, C.B., and Bartel, D.P. (2009). Most mammalian 
mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105. 
 
Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2009). Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol 10, 
R25. 
 
Picelli, S., Bjorklund, A.K., Faridani, O.R., Sagasser, S., Winberg, G., and Sandberg, R. 
(2013). Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat 
Methods 10, 1096-1098. 
 
Roberts, A., and Pachter, L. (2013). Streaming fragment assignment for real-time 
analysis of sequencing experiments. Nat Methods 10, 71-73. 
 
Satija, R., Farrell, J.A., Gennert, D., Schier, A.F., and Regev, A. (2015). Spatial 
reconstruction of single-cell gene expression data. Nature biotechnology. 
 
Ucar, A., Gupta, S.K., Fiedler, J., Erikci, E., Kardasinski, M., Batkai, S., Dangwal, S., 
Kumarswamy, R., Bang, C., Holzmann, A., et al. (2012). The miRNA-212/132 family 
regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3, 1078. 	  
